Your browser doesn't support javascript.
loading
Designing a decision aid for cancer prevention: a qualitative study.
Milton, Shakira; Macrae, Finlay; McIntosh, Jennifer G; Saya, Sibel; Alphonse, Pavithran; Yogaparan, Thivagar; Karnchanachari, Napin; Novy, Kitty; Nguyen, Peter; Lau, Phyllis; Emery, Jon.
Afiliación
  • Milton S; Centre for Cancer Research, University of Melbourne, Melbourne, Australia.
  • Macrae F; Department of General Practice, University of Melbourne, Melbourne, Australia.
  • McIntosh JG; Department of Medicine, The University of Melbourne, Melbourne, Australia.
  • Saya S; Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia.
  • Alphonse P; Centre for Cancer Research, University of Melbourne, Melbourne, Australia.
  • Yogaparan T; Department of General Practice, University of Melbourne, Melbourne, Australia.
  • Karnchanachari N; Centre for Cancer Research, University of Melbourne, Melbourne, Australia.
  • Novy K; Department of General Practice, University of Melbourne, Melbourne, Australia.
  • Nguyen P; Centre for Cancer Research, University of Melbourne, Melbourne, Australia.
  • Lau P; Department of General Practice, University of Melbourne, Melbourne, Australia.
  • Emery J; Centre for Cancer Research, University of Melbourne, Melbourne, Australia.
Fam Pract ; 2023 Apr 14.
Article en En | MEDLINE | ID: mdl-37058423
Aspirin can help to prevent bowel cancer up by to 25% and the chances of dying from it by up to 33%. Australian guidelines recommend that people aged 50­70 years old to consider taking low-dose aspirin to reduce their risk of bowel cancer. To encourage GPs and their patients to discuss the guidelines, we designed a brochure called a decision aid with the help of clinicians and people in the community of Victoria, Australia. The decision aid covered the benefits and risks of taking aspirin. Clinicians participated in interviews and provided feedback on the statistics presented in a chart called an expected frequency tree. People in the community participated in group discussions and improved the design and comprehension of the decision aid. The clinicians and people who participated in this study do not fully represent the diversity of the Australian population, as they were mostly white and highly educated. We are now testing if the decision aid is effective for supporting a discussion between patients and general practitioners, helping their patients make an informed decision about taking aspirin, and whether it encourages them to take aspirin daily after being shown the decision aid in general practice.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Fam Pract Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Fam Pract Año: 2023 Tipo del documento: Article País de afiliación: Australia